Article Text

Download PDFPDF
Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting
  1. Gwendolin Manegold-Brauer, MD,
  2. Johanna Buechel, MD,
  3. Alexandra Knipprath-Mészaros, MD,
  4. Andreas Schoetzau,
  5. Neville F. Hacker, MD,
  6. Sevgi Tercanli, MD,
  7. Olav Lapaire, MD and
  8. Viola Heinzelmann-Schwarz, MD
  1. * Hospital for Women, University Hospital Basel, Switzerland;
  2. Ovarian Cancer Research, Department of Biomedicine, University of Basel, Switzerland;
  3. Royal Hospital for Women, Gynecological Cancer Centre, School of Women’s and Children’s Health, University of New South Wales, Randwick, Australia; and
  4. § Practice for Prenatal and Gynecologic Ultrasound, Basel, Switzerland.
  1. Address correspondence and reprint requests to Gwendolin Manegold-Brauer, MD, Department of Ultrasound, Hospital for Women, University Hospital Basel, 4031 Basel, Switzerland. E-mail: gwendolin.manegold-brauer{at}usb.ch.

Abstract

Objective Preoperative assessment of adnexal masses with ultrasound has been shown to be time-, cost-effective, and specific. When used in combination with the menopausal status and the tumor marker CA125, the risk of malignancy index (RMI) can be calculated, allowing appropriate preoperative triage of patients to a gynecologist or a gynecological oncologist. Moreover, it allows for accurate planning of the required surgical procedure (laparoscopy vs laparotomy).

Methods A large general gynecologic ultrasonic database retrospectively identified 5218 patients for a 14-year period who presented to the outpatient clinic with an adnexal mass. Additional data (menopausal status, histology, CA125 values) were available in 1108 of these patients. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated. The results were then compared with previously published data from a large Australian gynecological cancer center (GCC, n = 204).

Results With the use of an RMI cutoff of 200, malignant ovarian tumors were correctly triaged to a gynecologic oncologist in 123 of 172 cases, leading to a sensitivity of 72% and specificity of 92% in our general outpatient clinic population compared with a sensitivity of 84% and a specificity of 77% in the GCC high-risk population. The negative predictive value was 95% compared with only 85% in the GCC cohort. We hypothesize that improvement of the overall detection rate of malignancy could be improved from 72% to 85% using a 2-step model, referring patients with an ultrasonic score of 3 to an experienced sonographer who uses pattern recognition.

Conclusions The RMI is an easy and reliable tool for the accurate triage of adnexal masses. Its value is higher in an unselected gynecological outpatient setting. Our proposed 2-step model including expert pattern recognition could influence particularly the detection rate in borderline and early-stage ovarian cancers and overcome the limitations of the tumor marker CA125.

  • Ovarian cancer
  • Adnexal mass
  • CA125
  • Ultrasound
  • Pattern recognition

Statistics from Altmetric.com

Footnotes

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.